Log in

TG Therapeutics SEC Filings & 10K Form (NASDAQ:TGTX)

$5.20
+0.02 (+0.39 %)
(As of 10/13/2019 04:00 PM ET)
Today's Range
$5.19
Now: $5.20
$5.33
50-Day Range
$5.07
MA: $5.98
$6.98
52-Week Range
$3.32
Now: $5.20
$9.38
Volume688,061 shs
Average Volume1.19 million shs
Market Capitalization$493.17 million
P/E RatioN/A
Dividend YieldN/A
Beta2.5

SEC Filings

TG Therapeutics (NASDAQ:TGTX) SEC Filings

DateFilerForm TypeView
09/18/2019
4:11 PM
Hoberman Kenneth (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
4:10 PM
Charney Laurence N (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
4:09 PM
Echelard Yann (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
4:09 PM
KENNEDY WILLIAM JAMES (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
4:09 PM
HUME DANIEL (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2019
8:25 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2019
3:17 PM
TG Therapeutics (Filer)
Form S-3ASR
09/05/2019
3:00 PM
TG Therapeutics (Filer)
Form RW
08/30/2019
3:16 PM
TG Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/09/2019
3:31 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
6:33 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
3:00 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2019
6:33 AM
TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
3:43 PM
TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:07 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2019
1:48 PM
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (Filed by)
TG Therapeutics (Subject)
Form PX14A6G
05/10/2019
3:01 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2019
6:01 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:35 PM
TG Therapeutics (Filer)
Form DEFA14A
04/01/2019
7:33 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2019
3:06 PM
BRIDGER MANAGEMENT, LLC (Filed by)
TG Therapeutics (Subject)
Form SC 13G
03/05/2019
8:01 AM
TG Therapeutics (Filer)
Form 424B5
03/05/2019
8:00 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
3:02 PM
TG Therapeutics (Filer)
Form 424B5
02/28/2019
6:33 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
4:14 PM
RA CAPITAL MANAGEMENT, LLC (Filed by)
TG Therapeutics (Subject)
Form SC 13G
02/14/2019
7:42 AM
STATE STREET CORP (Filed by)
TG Therapeutics (Subject)
Form SC 13G
02/14/2019
7:22 AM
TG Therapeutics (Subject)
venBio Select Advisor LLC (Filed by)
Form SC 13G
02/13/2019
11:06 AM
FMR LLC (Filed by)
TG Therapeutics (Subject)
Form SC 13G/A
01/22/2019
7:07 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
6:21 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2018
6:36 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2018
3:01 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2018
6:35 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2018
4:20 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2018
6:15 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2018
11:15 PM
TG Therapeutics (Filer)
Form EFFECT
07/11/2018
8:04 AM
LFB Biotechnologies S.A.S.U. (Filed by)
TG Therapeutics (Subject)
Form SC 13D/A
07/09/2018
4:01 PM
TG Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/05/2018
4:00 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
4:59 PM
Charney Laurence N (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
4:00 PM
Hoberman Kenneth (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
4:00 PM
KENNEDY WILLIAM JAMES (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
4:00 PM
TG Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
4:00 PM
HUME DANIEL (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
4:00 PM
Echelard Yann (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
4:00 PM
SCHOENEBAUM MARK (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2018
3:31 PM
TG Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/20/2018
7:00 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2018
4:09 PM
LFB Biotechnologies S.A.S.U. (Filed by)
TG Therapeutics (Subject)
Form SC 13D/A
06/13/2018
3:35 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2018
3:30 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2018
3:30 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
3:01 PM
TG Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
6:37 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2018
3:01 PM
TG Therapeutics (Filer)
Form DEFA14A
04/30/2018
3:00 PM
TG Therapeutics (Filer)
Form DEF 14A
04/24/2018
3:30 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2018
4:29 PM
TG Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/08/2018
6:34 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2018
8:00 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2018
8:30 AM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2018
4:25 PM
Power Sean A (Reporting)
TG Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2017
3:15 PM
TG Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 10/13/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel